Head to head
Hims vs Noom (Noom Med)
Both are real, operating US telehealth companies. What separates them is what they supply, what they charge for it, and what regulators have published about each — all of it below, linked to the primary documents.
- Hims
- FDA-approved
$149/mo - Noom (Noom Med)
- Both
$179/mo - Hims on file
- 5
- Noom (Noom Med) on file
- 2
Side by side
What each one publishes about itself
Every figure here is the provider’s own advertised number, not an estimate. A dash means the company does not publish it.
| Hims | Noom (Noom Med) | |
|---|---|---|
| Supplies | FDA-approved medication only | Compounded and branded |
| Advertised from | $149/mo | $179/mo |
| First month | $39 | $49 |
| Medication in the price | Billed separately | Included |
| Insurance | Cash pay | Both |
| Intake | Async | Async |
| On the record | 5 actions | 2 actions |
The difference that actually matters
Hims: Supplies FDA-approved medication only — Wegovy, Zepbound, Ozempic, Mounjaro or the approved oral versions. Higher priced, and outside the compounding enforcement entirely. Noom (Noom Med): Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to.
What is on Hims’s record
2025-09
FDA warning letter to Hims & Hers Health, Inc. dba Hims (MARCS-CMS 716567) over compounded GLP-1 marketing.
2025-06
Novo Nordisk terminated its collaboration with Hims & Hers, alleging illegal sham compounding and Chinese-sourced unapproved API.
2026-03
Novo Nordisk patent infringement suit filed February 2026 was dropped 9 March 2026 under a settlement in which Hims agreed to stop promoting compounded GLP-1s.
What is on Noom (Noom Med)’s record
2026-05
NAD (BBB National Programs) decision, challenged by Eli Lilly, recommended Noom discontinue or modify its 'Microdose GLP-1Rx' claims for lack of support that the lower dose delivers a measurable health benefit; Noom disagreed but agreed to comply.
$62M class action settlement (Mahood v. Noom) over auto-enrollment and auto-renewal practices, final approval granted.
Go direct
Both companies, and what we earn from each
We do not recommend one over the other. Where a link pays us, it says so here and on the provider’s own page.
Hims
FDA-approved medication only, from $149 a month. 5 actions on record, each linked on its page. The link below earns us nothing.
Noom (Noom Med)
Compounded and branded, from $179 a month. 2 actions on record, each linked on its page. The link below earns us nothing.
Straight answers
Hims vs Noom (Noom Med), in short
- Is Hims or Noom (Noom Med) cheaper?
- Hims advertises the lower starting price — $149 a month against $179. Whether that is the cheaper purchase depends on what each figure covers: Hims bills medication separately, and Noom (Noom Med) includes it.
- What is the difference between Hims and Noom (Noom Med)?
- Hims: FDA-approved medication only. Noom (Noom Med): both compounded and FDA-approved medication. One of the two sells both categories, so its advertised headline price almost certainly refers to the compounded option.
- Which one has more regulatory actions on record?
- Hims, with 5 sourced actions against 2 actions for Noom (Noom Med). Every one is linked to its primary document on the provider's own page. A larger file is not automatically a worse company — read what the documents actually say.
Other comparisons: Hims vs Ro (Ro Body) · Hims vs Hers · Hims vs Calibrate · Ro (Ro Body) vs Noom (Noom Med) · Noom (Noom Med) vs Found · Noom (Noom Med) vs WeightWatchers Clinic